Search Results

There are 10291 results for: content related to: 3,4-Dihydroxybenzalacetone Protects Against Parkinson's Disease-Related Neurotoxin 6-OHDA Through Akt/Nrf2/Glutathione Pathway

  1. Simultaneous intrastriatal and intranigral dopaminergic grafts in the parkinsonian rat model: Role of the intranigral graft

    Journal of Comparative Neurology

    Volume 426, Issue 1, 9 October 2000, Pages: 106–116, K. Adam Baker, Damaso Sadi, Murray Hong and Ivar Mendez

    Version of Record online : 5 SEP 2000, DOI: 10.1002/1096-9861(20001009)426:1<106::AID-CNE7>3.0.CO;2-Z

  2. Influence of 6-Hydroxydopamine Toxicity on α-Synuclein Phosphorylation, Resting Vesicle Expression, and Vesicular Dopamine Release

    Journal of Cellular Biochemistry

    Volume 117, Issue 12, December 2016, Pages: 2719–2736, Kavina Ganapathy, Indrani Datta, Sowmithra Sowmithra, Preeti Joshi and Ramesh Bhonde

    Version of Record online : 5 MAY 2016, DOI: 10.1002/jcb.25570

  3. You have free access to this content
    Effect of sublethal 6-hydroxydopamine on the response to subsequent oxidative stress in dopaminergic cells: evidence for preconditioning

    Journal of Neurochemistry

    Volume 99, Issue 4, November 2006, Pages: 1151–1163, Rehana K. Leak, Anthony K. F. Liou and Michael J. Zigmond

    Version of Record online : 21 AUG 2006, DOI: 10.1111/j.1471-4159.2006.04149.x

  4. p-quinone mediates 6-hydroxydopamine-induced dopaminergic neuronal death and ferrous iron accelerates the conversion of p-quinone into melanin extracellularly

    Journal of Neuroscience Research

    Volume 79, Issue 6, 15 March 2005, Pages: 849–860, Yasuhiko Izumi, Hideyuki Sawada, Noriko Sakka, Noriyuki Yamamoto, Toshiaki Kume, Hiroshi Katsuki, Shun Shimohama and Akinori Akaike

    Version of Record online : 11 FEB 2005, DOI: 10.1002/jnr.20382

  5. You have free access to this content
    Effects of 6-hydroxydopamine on primary cultures of substantia nigra: specific damage to dopamine neurons and the impact of glial cell line-derived neurotrophic factor

    Journal of Neurochemistry

    Volume 89, Issue 3, May 2004, Pages: 776–787, Yun Min Ding, Juliann D. Jaumotte, Armando P. Signore and Michael J. Zigmond

    Version of Record online : 30 MAR 2004, DOI: 10.1111/j.1471-4159.2004.02415.x

  6. New ghrelin agonist, HM01 alleviates constipation and L-dopa-delayed gastric emptying in 6-hydroxydopamine rat model of Parkinson's disease

    Neurogastroenterology & Motility

    Volume 26, Issue 12, December 2014, Pages: 1771–1782, H. Karasawa, C. Pietra, C. Giuliano, S. Garcia-Rubio, X. Xu, S. Yakabi, Y. Taché and L. Wang

    Version of Record online : 19 OCT 2014, DOI: 10.1111/nmo.12459

  7. 6-hydroxydopamine induces dopaminergic cell degeneration via a caspase-9-mediated apoptotic pathway that is attenuated by caspase-9dn expression

    Journal of Neuroscience Research

    Volume 77, Issue 5, 1 September 2004, Pages: 747–761, Qinghua Liang, Anthony K.F. Liou, Yunmin Ding, Guodong Cao, Xiao Xiao, Ruth G. Perez and Jun Chen

    Version of Record online : 16 JUL 2004, DOI: 10.1002/jnr.20198

  8. Combined ipsilateral limb use score as an index of motor deficits and neurorestoration in parkinsonian rats

    Journal of Neuroscience Research

    Juuso V. Leikas, Tiina M. Kääriäinen, Aaro J. Jalkanen, Marko Lehtonen, Tomi Rantamäki and Markus M. Forsberg

    Version of Record online : 30 JAN 2017, DOI: 10.1002/jnr.24022

  9. You have free access to this content
    Erythropoietin protects against 6-hydroxydopamine-induced dopaminergic cell death

    Journal of Neurochemistry

    Volume 96, Issue 2, January 2006, Pages: 428–443, Armando P. Signore, Zhongfang Weng, Teresa Hastings, Amber D. Van Laar, Qinghua Liang, Yong J. Lee and Jun Chen

    Version of Record online : 8 DEC 2005, DOI: 10.1111/j.1471-4159.2005.03587.x

  10. You have free access to this content
    Therapeutic Effects of Fucoidan in 6-Hydroxydopamine-Lesioned Rat Model of Parkinson's disease: Role of NADPH oxidase-1

    CNS Neuroscience & Therapeutics

    Volume 20, Issue 12, December 2014, Pages: 1036–1044, Fei-Long Zhang, Yi He, Yan Zheng, Wen-Jing Zhang, Qi Wang, Yan-Jun Jia, Hai-Long Song, Hai-Ting An, Hao-Bo Zhang, Yan-Jing Qian, Yu-Long Tong, Lin Dong and Xiao-Min Wang

    Version of Record online : 15 NOV 2014, DOI: 10.1111/cns.12340

  11. You have free access to this content
    6-Hydroxydopamine activates the mitochondrial apoptosis pathway through p38 MAPK-mediated, p53-independent activation of Bax and PUMA

    Journal of Neurochemistry

    Volume 104, Issue 6, March 2008, Pages: 1599–1612, Maria Gomez-Lazaro, Maria F. Galindo, Caoimhín G. Concannon, Miguel F. Segura, Francisco J. Fernandez-Gomez, Nuria Llecha, Joan X. Comella, Jochen H. M. Prehn and Joaquin Jordan

    Version of Record online : 7 NOV 2007, DOI: 10.1111/j.1471-4159.2007.05115.x

  12. You have full text access to this OnlineOpen article
    Reduced vocal variability in a zebra finch model of dopamine depletion: implications for Parkinson disease

    Physiological Reports

    Volume 3, Issue 11, November 2015, Julie E. Miller, George W. Hafzalla, Zachary D. Burkett, Cynthia M. Fox and Stephanie A. White

    Version of Record online : 12 NOV 2015, DOI: 10.14814/phy2.12599

  13. Rapid activation of ERK by 6-hydroxydopamine promotes survival of dopaminergic cells

    Journal of Neuroscience Research

    Volume 86, Issue 1, January 2008, Pages: 108–117, Eva Lin, Jane E. Cavanaugh, Rehana K. Leak, Ruth G. Perez and Michael J. Zigmond

    Version of Record online : 10 SEP 2007, DOI: 10.1002/jnr.21478

  14. You have free access to this content
    Autoxidation and Neurotoxicity of 6-Hydroxydopamine in the Presence of Some Antioxidants

    Journal of Neurochemistry

    Volume 74, Issue 4, April 2000, Pages: 1605–1612, Ramón Soto-Otero, Estefanía Méndez-Álvarez, Álvaro Hermida-Ameijeiras, Ana María Muñoz-Patiño and José Luis Labandeira-Garcia

    Version of Record online : 18 JAN 2002, DOI: 10.1046/j.1471-4159.2000.0741605.x

  15. Neuroprotective effects of novel phosphatidylglycerol-based phospholipids in the 6-hydroxydopamine model of Parkinson's disease

    European Journal of Neuroscience

    Volume 27, Issue 2, January 2008, Pages: 294–300, S. Crotty, P. Fitzgerald, E. Tuohy, D. M. Harris, A. Fisher, A. Mandel, A. E. Bolton, A. M. Sullivan and Y. Nolan

    Version of Record online : 11 JAN 2008, DOI: 10.1111/j.1460-9568.2007.06018.x

  16. 3-[(2,4-dimethoxy)benzylidene]-anabaseine dihydrochloride protects against 6-hydroxydopamine-induced parkinsonian neurodegeneration through α7 nicotinic acetylcholine receptor stimulation in rats

    Journal of Neuroscience Research

    Volume 91, Issue 3, March 2013, Pages: 462–471, Syuuichirou Suzuki, Jun Kawamata, Takashi Matsushita, Akihiro Matsumura, Shin Hisahara, Kazuyuki Takata, Yoshihisa Kitamura, William Kem and Shun Shimohama

    Version of Record online : 14 DEC 2012, DOI: 10.1002/jnr.23160

  17. In vivo magnetic resonance imaging characterization of bilateral structural changes in experimental Parkinson’s disease: a T2 relaxometry study combined with longitudinal diffusion tensor imaging and manganese-enhanced magnetic resonance imaging in the 6-hydroxydopamine rat model

    European Journal of Neuroscience

    Volume 33, Issue 8, April 2011, Pages: 1551–1560, Guadalupe Soria, Esther Aguilar, Raúl Tudela, Joaquim Mullol, Anna M. Planas and Concepció Marin

    Version of Record online : 17 MAR 2011, DOI: 10.1111/j.1460-9568.2011.07639.x

  18. You have free access to this content
    Neuroblastoma Cells Expressing the Noradrenaline Transporter Are Destroyed More Selectively by 6-Fluorodopamine than by 6-Hydroxydopamine

    Journal of Neurochemistry

    Volume 75, Issue 2, August 2000, Pages: 511–520, Gabriele Seitz, Hartmut B Stegmann, Heidrun H Jäger, Hans M Schlude, Hartwig Wolburg, Vitaly A Roginsky, Dietrich Niethammer and Gernot Bruchelt

    Version of Record online : 4 JAN 2002, DOI: 10.1046/j.1471-4159.2000.0750511.x

  19. You have free access to this content
    Mechanism of 6-hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6-hydroxydopamine-induced degeneration of dopaminergic neurons

    Journal of Neurochemistry

    Volume 103, Issue 1, October 2007, Pages: 145–156, J. Rodriguez-Pallares, J. A. Parga, A. Muñoz, P. Rey, M. J. Guerra and J. L. Labandeira-Garcia

    Version of Record online : 22 MAY 2007, DOI: 10.1111/j.1471-4159.2007.04699.x

  20. You have free access to this content
    Simvastatin Induces Neuroprotection in 6-OHDA-Lesioned PC12 via the PI3K/AKT/Caspase 3 Pathway and Anti-Inflammatory Responses

    CNS Neuroscience & Therapeutics

    Volume 19, Issue 3, March 2013, Pages: 170–177, Yun-Qi Xu, Ling Long, Jun-Qiang Yan, Lei Wei, Meng-Qiu Pan, Hui-Min Gao, Peng Zhou, Mei Liu, Can-Sheng Zhu, Bei-Sha Tang and Qing Wang

    Version of Record online : 28 DEC 2012, DOI: 10.1111/cns.12053